80 Results for "

methotrexate-

" in MedChemExpress (MCE) Product Catalog:
Products (80)

80 Results for "methotrexate-" in MCE Product Catalog:

Cat. No.: HY-W745177
Methotrexate-d3 Pentaglutamate Trifluoroacetate is the deuterium labeled Methotrexate Pentaglutamate Trifluoroacetate.
loading...
    loading...
Cat. No.: HY-165164
CAS No.: 116819-28-4
Target:  

Drug Intermediate

Research Areas:  

Cancer

Methotrexate-alpha-alanine is a prodrug for activation by enzyme-monoclonal antibody conjugates of Methotrexate (HY-14519). Methotrexate-alpha-alanine shows cytotoxicity .
loading...
    loading...
Cat. No.: HY-108251R
CAS No.: 19741-14-1
Synonyms: DAMPA (Standard)
Methotrexate metabolite (Standard) is the analytical standard of Methotrexate metabolite. This product is intended for research and analytical applications. Methotrexate metabolite (DAMPA), the active metabolite of Methotrexate. Methotrexate is a folic acid antagonist that is widely used as an immunosuppressant and chemotherapeutic agent .
loading...
    loading...
Cat. No.: HY-148994
CAS No.: 64801-58-7
Research Areas:  

Cancer

Methotrexate-γ-aspartate is a Ll210 cell dihydrofolate reductase inhibitor. Methotrexate-γ-aspartate is apparently more resistant to enzymic cleavage than is methotrexate-y-glutamate. Methotrexate-γ-aspartate can be used in antibody-targeted liposomes and is promising for research of leukemic .
loading...
    loading...
Cat. No.: HY-P991641
Synonyms: LY3012218

Target:  

FLT3 p38 MAPK STAT PI3K Akt

Research Areas:  

Cancer

IMC-EB10 (LY3012218) is an anti-FLT3 monoclonal antibody. IMC-EB10 binds to FLT3 with high affinity (Kd = 158 pM) and blocks the binding of FLT3 ligand to FLT3 (IC50 ≈ 10 nM), thereby inhibiting MAPK, STAT5, and PI3K/Akt signaling in leukemia cells. IMC-EB10 can enhance the anti-leukemic effect of Methotrexate (HY-14519) and inhibit leukemias expressing wild-type or ITD-mutated FLT3 receptors. IMC-EB10 prolongs the survival of acute lymphoblastic leukemia (ALL) cells and primary leukemia samples and reduces engraftment in non-obese diabetic/severe combined immunodeficiency patients. IMC-EB10 is indicated for leukemia research .
loading...
    loading...
Cat. No.: HY-W769792
Methotrexate-d3 Diglutamate TFA Sulfate is the deuterium labeled Methotrexate Diglutamate TFA Sulfate.
loading...
    loading...
Cat. No.: HY-14519S1
Purity:  99.69%
Methotrexate-d3 diammonium is the deuterated-labeled Methotrexate (HY-14519). Methotrexate (Amethopterin; CL14377; WR19039) is an orally active antifolate (Antifolate). Methotrexate inhibits dihydrofolate reductase (DHFR), blocks tetrahydrofolate production, suppresses purine/pyrimidine synthesis and transmethylation, and causes intracellular accumulation of AICAR. Methotrexate promotes extracellular adenosine release, regulates the cytokine network, and inhibits the alarmin function of HMGB1. Methotrexate induces apoptosis and cytotoxicity, upregulates the expression of iNOS and COX-2, suppresses hippocampal neurogenesis, and induces pulmonary fibrosis. Methotrexate is used in the research of various immune and inflammation-related diseases such as arthritis, psoriasis, systemic lupus erythematosus, as well as pulmonary fibrosis and breast cancer .
loading...
    loading...
Cat. No.: HY-108251S
CAS No.: 1794780-00-9
Synonyms: DAMPA-d3
Methotrexate metabolite-d3 is the deuterium labeled Methotrexate metabolite. Methotrexate metabolite (DAMPA), the active metabolite of Methotrexate. Methotrexate is a folic acid antagonist that is widely used as an immunosuppressant and chemotherapeutic agent .
loading...
    loading...
Cat. No.: HY-W654227
7-Hydroxy methotrexate-d3 (ammonium salt) is deuterium labeled 7-Hydroxymethotrexate. 7-Hydroxymethotrexate is a major metabolite of Methotrexate (MTX; HY-14519). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
loading...
    loading...
Cat. No.: HY-148657
CAS No.: 98457-88-6
Synonyms: NHS-methotrexate
Target:  

Others

Research Areas:  

Inflammation/Immunology Cancer

Aminopterin N-hydroxysuccinimide ester(NHS-methotrexate) is an irreversible Methotrexate (HY-14519) influx carrier inhibitor. Aminopterin N-hydroxysuccinimide ester can be used for the research of rheumatoid arthritis and a number of cancers (such as acute lymphoblastic leukemia) .
loading...
    loading...
Cat. No.: HY-121151S
Synonyms: (±)-Amethopterin-d3; (±)-CL14377-d3; (±)-WR19039-d3
(±)-Methotrexate-d3 ((±)-Amethopterin-d3; (±)-CL14377-d3; (±)-WR19039-d3) is the deuterated-labeled (±)-Methotrexate (HY-121151). (±)-Methotrexate is the racemate of Methotrexate (HY-14519). Methotrexate is an orally active antifolate (Antifolate). Methotrexate inhibits dihydrofolate reductase (DHFR), blocks tetrahydrofolate production, suppresses purine/pyrimidine synthesis and transmethylation, and causes intracellular accumulation of AICAR. Methotrexate promotes extracellular adenosine release, regulates the cytokine network, and inhibits the alarmin function of HMGB1. Methotrexate induces apoptosis and cytotoxicity, upregulates the expression of iNOS and COX-2, suppresses hippocampal neurogenesis, and induces pulmonary fibrosis. Methotrexate is used in the research of various immune and inflammation-related diseases such as arthritis, psoriasis, systemic lupus erythematosus, as well as pulmonary fibrosis and breast cancer .
loading...
    loading...
Cat. No.: HY-17556B
CAS No.: 1097832-14-8
Synonyms: Leucovorin calcium hydrate
Folinic acid (Leucovorin) calcium hydrate is a biological folic acid and is generally administered along with Methotrexate (HY-14519) as a rescue agent to decrease Methotrexate-induced toxicity .
loading...
    loading...
Cat. No.: HY-121256
CAS No.: 18921-73-8
Chlorasquin inhibits thymidylate synthetase with an approximate Ki value of 4.9 μM. Chlorasquin is also a folate antagonist, testing the Methotrexate (HY-14519) effect. Chlorasquin binds tighter to dihydrofolate reductase at alkaline pH than does Methotrexate, which is promising for research of antipsoriatic agents .
loading...
    loading...
Cat. No.: HY-130569S
7-Hydroxymethotrexate-d3 (sodium) is deuterium labeled 7-Hydroxymethotrexate. 7-Hydroxymethotrexate is a major metabolite of Methotrexate (HY-14519). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
loading...
    loading...
Cat. No.: HY-130569S1
CAS No.: 432545-62-5
7-Hydroxymethotrexate-d3 is the deuterium labeled 7-Hydroxymethotrexate. 7-Hydroxymethotrexate is a major metabolite of Methotrexate (HY-14519). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
loading...
    loading...
Cat. No.: HY-108807
CAS No.: 1622456-55-6
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease Cancer

Glucarpidase is an enzyme that inactivates methotrexate. Glucarpidase can be used for renal dysfunction diseases research .
loading...
    loading...
Cat. No.: HY-137020
CAS No.: 751-75-7
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

7-Hydroxydichloromethotrexate is a methotrexate metabolite which can be isolated from the urine of rabbits .
loading...
    loading...
Cat. No.: HY-130569S2
7-Hydroxymethotrexate-d3 (ammonium) is the deuterium labeled 7-Hydroxymethotrexate ammonium. 7-Hydroxymethotrexate is a major metabolite of Methotrexate (HY-14519). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
loading...
    loading...
Cat. No.: HY-123098
CAS No.: 4299-28-9
Research Areas:  

Cancer

Tetrahydromethotrexate is a more potent folate antagonist than Methotrexate (HY-14519) in studies against certain bacteria (Streptococcus faecalis, Pediococcus erevisiae) and in animal models. Tetrahydromethotrexate is used in the research of cancer and autoimmune diseases .
loading...
    loading...
Cat. No.: HY-167863
CAS No.: 79483-69-5
Synonyms: BW 301U isethionate; NSC 351521 isethionate
Piritrexim isethionate (BW 301U isethionate) is a fat-soluble dihydrofolate reductase inhibitor with activity in the treatment of severe psoriasis. Piritrexim isethionate may be as effective as methotrexate in the treatment of severe psoriasis and may have less hepatotoxicity .
loading...
    loading...